RHHBF Roche Holding

Roche Holding AG operates as a research healthcare company. It operates through the following segments: Diagnostics and Pharmaceuticals. The Pharmaceutical segment refers to development of medicines in the field of oncology, immunology, ophthalmology, infectious diseases and neuroscience. The Diagnostic segment refers to diagnosis of diseases through an in vitro diagnostics process. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Company profile

Severin Schwan

RHHBF stock data



2 Dec 21

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

6.9% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 104 115 -9.6%
Opened positions 7 11 -36.4%
Closed positions 18 9 +100.0%
Increased positions 22 30 -26.7%
Reduced positions 41 39 +5.1%
13F shares
Current Prev Q Change
Total value 5.01B 1.01B +394.8%
Total shares 11.12M 21.55M -48.4%
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Fisher Asset Management 3.59M $164.67M +41.0%
Saratoga Research & Investment Management 1.1M $50.23M -0.1%
Cullen Capital Management 1.05M $47.86M +0.7%
Bristol John W & Co 843.7K $38.36M -1.0%
Boston Common Asset Management 475.54K $21.79M +19.2%
Osher Van de Voorde Investment Management 288.98K $13.14M +4.0%
Veredus Asset Management 265.08K $12.05M +0.9%
Kornitzer Capital Management 259.48K $11.89M -0.3%
Hikari Power 230.22K $10.47M 0.0%
RUG Renaissance 199.25K $9.06M -7.3%
Largest transactions
Shares Bought/sold Change
Parametric Portfolio Associates 0 -6.19M EXIT
ARK Investment Management 1.04K -5M -100.0%
Fisher Asset Management 3.59M +1.05M +41.0%
Oxbow Advisors 0 -272.19K EXIT
Scout Investments 78.21K +78.21K NEW
Boston Common Asset Management 475.54K +76.75K +19.2%
Diversified Trust 0 -64.33K EXIT
Bowen Hanes & Co 64.91K +32.42K +99.8%
Kempner Capital Management 72.89K -24.31K -25.0%
Fairfield, Bush & Co. 15K -18.62K -55.4%

Financial reports

No filings

Current reports

No filings